Retreatment of Chronic Hepatitis C Failed to Daclatasvir Plus Asunaprevir by Other Direct-acting Antivirals

Retreatment of Chronic Hepatitis C Failed to Daclatasvir Plus Asunaprevir by Other Direct-acting Antivirals

The pegylated interferon plus ribavirin combination therapy has been used as the primary treatment for chronic hepatitis C (CHC) but fails to produce a sustained viral response (SVR) in many patients. In recent years, the treatment of CHC has been rapidly changing because of the introduction of dire...

Full description

Bibliographic Details
Main Authors: Dong Hoon Lee, Soo Hyung Ryu, Hee jun Myung, Yun Jae Shin, Si Hyeong Lee, Tae Young Park, Jeong Seop Moon
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2021-02-01
Series:The Korean Journal of Gastroenterology
Subjects:
hepatitis c
chronic
antiviral agents
daclatasvir
asunaprevir
Online Access:http://www.kjg.or.kr/journal/view.html?uid=5675&vmd=Full

Internet

http://www.kjg.or.kr/journal/view.html?uid=5675&vmd=Full

Similar Items